SCHEMBL1896358

SCHEMBL1896358

[CH2]C([CH2])n1ccc2c(N)cccc2c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.47
ALDH1A1 P00352 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
CYP3A4 P08684 2/20 0.45
HPGD P15428 2/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
RECQL P46063 1/20 0.40
NR4A2 P43354 1/20 0.37
MEN1 O00255 2/20 0.36
USP2 O75604 2/20 0.36
KMT2A Q03164 2/20 0.36
TTR P02766 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP2 O95551 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27776468 0.87 PARP1 (0.44) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL30349861 0.83 PARP1 (0.47) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL1896101 0.79 MGLL (0.34) CYP3A4TSHRKDM4ETYMS
SCHEMBL12668521 0.79 PARP1 (0.47) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL1590518 0.79 PARP1 (0.50) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL12702817 0.79 PARP1 (0.47) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL12702932 0.78 PARP1 (0.46) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL12668528 0.78 PARP1 (0.46) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL1589819 0.76 PARP1 (0.48) PARP1ALDH1A1TDP1CYP3A4HPGD
SCHEMBL1590034 0.76 PARP1 (0.48) PARP1ALDH1A1TDP1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937643-B1 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF SECOND GENOME INC (US) 2016-07-13 EP disclosed
US-8779144-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2014-07-15 US disclosed
US-20110118287-A1 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof RENOVIS, INC. (US) 2011-05-19 US disclosed
US-20100184802-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2010-07-22 US disclosed
EP-1937643-A2 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF Renovis, Inc. (US) 2008-07-02 EP disclosed
WO-2007109160-A9 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF RENOVIS INC (US) 2007-11-15 WO disclosed
WO-2007109201-A2 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF RENOVIS, INC. (US) 2007-09-27 WO disclosed
WO-2007109160-A2 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF RENOVIS, INC. (US) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118287-A1 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX1 PARP1 1784/4885ALDH1A1 3160/4885TDP1 2212/4885
US-20100184802-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 PARP1 1754/4885ALDH1A1 3640/4885TDP1 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.